Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the mosquito, the malaria parasite undergoes a complex and delicate lifecycle that can be successfully targeted using transmission blocking vaccines (TBVs). The most promising lifecycle stages to target with
-
design of experiments methods, based on Bayesian Optimisation. In addition, the team at Cambridge has its own high-throughput and robotics facilities which we use as a testbed in developing new ML methods
-
probability, likelihoods and Bayesian analysis. We are also seeking individuals with a strong interest in public health. Key Responsibilities: Develop models that integrate different data types (e.g., serology
-
identifying therapeutic targets and how to stratify patients. The UK Dementia Research Institute (UK DRI) is the biggest UK initiative driving forward research to fill this gap. We are a globally leading
-
therapeutic strategies targeted to different patient subgroups. The successful candidate will contribute to an expanding program of research investigating the role of immune activation in the progression
-
directorate and with teams across the Museum, the role holder will use data-driven insights, creative ideas, and strong interpersonal and organisational skills to achieve agreed KPIs and targets. With strategic
-
computational biology specifically targeting kinases would be advantageous. The successful candidate should show initiative and independent thinking, possess excellent communication skills and the ability to work
-
, to meet targets and deadlines, and be able to deal with pressure. They will have high levels of accuracy and attention to detail and an ability to quickly learn new records and reporting systems
-
human disease modelling, therapeutic target discovery, functional genomics and Artificial Intelligence/Machine Learning. The Enterprise arm of the MTI provides a comprehensive support system, which is
-
anti-cancer T cell bioengineering, integrating advanced molecular biology and immunological techniques to better understand the mechanisms by which T cells can be engineered to target and destroy cancer